152 related articles for article (PubMed ID: 32432845)
1. Exposure Variability and Target Attainment of Vancomycin: A Systematic Review Comparing Intermittent and Continuous Infusion.
van Maarseveen EM; Gipmans SGH; van Zanten ARH
Ther Drug Monit; 2020 Jun; 42(3):381-391. PubMed ID: 32432845
[TBL] [Abstract][Full Text] [Related]
2. Switching From Intermittent to Continuous Infusion of Vancomycin in Critically Ill Patients: Toward a More Robust Exposure.
van Maarseveen EM; Gipmans S; Vasbinder E; Petjak M; van Zanten AR
Ther Drug Monit; 2016 Jun; 38(3):398-401. PubMed ID: 26926670
[TBL] [Abstract][Full Text] [Related]
3. Continuous versus intermittent infusion of vancomycin for the treatment of Gram-positive infections: systematic review and meta-analysis.
Cataldo MA; Tacconelli E; Grilli E; Pea F; Petrosillo N
J Antimicrob Chemother; 2012 Jan; 67(1):17-24. PubMed ID: 22028203
[TBL] [Abstract][Full Text] [Related]
4. Continuous Versus Intermittent Infusion of Vancomycin and the Risk of Acute Kidney Injury in Critically Ill Adults: A Systematic Review and Meta-Analysis.
Flannery AH; Bissell BD; Bastin MT; Morris PE; Neyra JA
Crit Care Med; 2020 Jun; 48(6):912-918. PubMed ID: 32317590
[TBL] [Abstract][Full Text] [Related]
5. [Continuous and intermittent infusion of vancomycin equally effective: review of the literature].
van Maarseveen EM; Man WH; Touw DJ; Bouma AW; van Zanten AR
Ned Tijdschr Geneeskd; 2011; 155(42):A2667. PubMed ID: 22027450
[TBL] [Abstract][Full Text] [Related]
6. Design and prospective validation of a dosing instrument for continuous infusion of vancomycin: a within-population approach.
van Maarseveen EM; Bouma A; Touw DJ; Neef C; van Zanten AR
Eur J Clin Pharmacol; 2014 Nov; 70(11):1353-9. PubMed ID: 25168621
[TBL] [Abstract][Full Text] [Related]
7. Target-Controlled Continuous Infusion for Antibiotic Dosing: Proof-of-Principle in an In-silico Vancomycin Trial in Intensive Care Unit Patients.
Colin PJ; Jonckheere S; Struys MMRF
Clin Pharmacokinet; 2018 Nov; 57(11):1435-1447. PubMed ID: 29512049
[TBL] [Abstract][Full Text] [Related]
8. The pharmacokinetic/pharmacodynamic rationale for administering vancomycin via continuous infusion.
Waineo MF; Kuhn TC; Brown DL
J Clin Pharm Ther; 2015 Jun; 40(3):259-65. PubMed ID: 25865426
[TBL] [Abstract][Full Text] [Related]
9. Neonatal vancomycin continuous infusion: still a confusion?
Gwee A; Cranswick N; Metz D; Coghlan B; Daley AJ; Bryant PA; Curtis N
Pediatr Infect Dis J; 2014 Jun; 33(6):600-5. PubMed ID: 24378952
[TBL] [Abstract][Full Text] [Related]
10. Continuous intravenous administration of vancomycin in medical intensive care unit patients.
Saugel B; Nowack MC; Hapfelmeier A; Umgelter A; Schultheiss C; Thies P; Phillip V; Eyer F; Schmid RM; Huber W
J Crit Care; 2013 Feb; 28(1):9-13. PubMed ID: 22459156
[TBL] [Abstract][Full Text] [Related]
11. A higher dose of vancomycin in continuous infusion is needed in critically ill patients.
Jeurissen A; Sluyts I; Rutsaert R
Int J Antimicrob Agents; 2011 Jan; 37(1):75-7. PubMed ID: 21074374
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Continuous Infusion Vancomycin Administration in a Critically Ill Trauma Population.
Bissell BD; Riggi G; Morrison C
J Intensive Care Med; 2020 Jun; 35(6):570-575. PubMed ID: 29642744
[TBL] [Abstract][Full Text] [Related]
13. Observational clinical study on the effects of different dosing regimens on vancomycin target levels in critically ill patients: Continuous versus intermittent application.
Tafelski S; Nachtigall I; Troeger U; Deja M; Krannich A; Günzel K; Spies C;
J Infect Public Health; 2015; 8(4):355-63. PubMed ID: 25794497
[TBL] [Abstract][Full Text] [Related]
14. Fluctuations in vancomycin CNS tissue concentrations following intermittent and continuous infusions in the rat.
Luer MS; Neill KK; Gurley BJ; Shannon ML; Killian AD; Rodvold KA
Neurol Res; 2004 Apr; 26(3):312-5. PubMed ID: 15142325
[TBL] [Abstract][Full Text] [Related]
15. Impact of vancomycin protein binding on target attainment in critically ill children: back to the drawing board?
De Cock PA; Desmet S; De Jaeger A; Biarent D; Dhont E; Herck I; Vens D; Colman S; Stove V; Commeyne S; Vande Walle J; De Paepe P
J Antimicrob Chemother; 2017 Mar; 72(3):801-804. PubMed ID: 27999035
[TBL] [Abstract][Full Text] [Related]
16. Review of continuous-infusion vancomycin.
DiMondi VP; Rafferty K
Ann Pharmacother; 2013 Feb; 47(2):219-27. PubMed ID: 23386074
[TBL] [Abstract][Full Text] [Related]
17. Continuous intravenous vancomycin in children with normal renal function hospitalized in hematology-oncology: prospective validation of a dosing regimen optimizing steady-state concentration.
Hoegy D; Goutelle S; Garnier N; Rénard C; Faure-Conter C; Bergeron C; Bertrand Y; Bleyzac N
Fundam Clin Pharmacol; 2018 Jun; 32(3):323-329. PubMed ID: 29315849
[TBL] [Abstract][Full Text] [Related]
18. Protocol for a randomised controlled trial of continuous infusions of vancomycin to improve the attainment of target vancomycin levels in young infants: The VANC trial.
Gwee A; Cranswick N; Donath SM; Hunt R; Curtis N
BMJ Open; 2018 Nov; 8(11):e022603. PubMed ID: 30391914
[TBL] [Abstract][Full Text] [Related]
19. Determination of optimal loading and maintenance doses for continuous infusion of vancomycin in critically ill patients: Population pharmacokinetic modelling and simulations for improved dosing schemes.
Vu DH; Nguyen DA; Delattre IK; Ho TT; Do HG; Pham HN; Dao XC; Tran NT; Nguyen GB; Van Bambeke F; Tulkens PM; Nguyen HA
Int J Antimicrob Agents; 2019 Dec; 54(6):702-708. PubMed ID: 31600554
[TBL] [Abstract][Full Text] [Related]
20. Achievement of Therapeutic Vancomycin Exposure With Continuous Infusion in Critically Ill Children.
Genuini M; Oualha M; Bouazza N; Moulin F; Treluyer JM; Lesage F; Renolleau S; Benaboud S
Pediatr Crit Care Med; 2018 Jun; 19(6):e263-e269. PubMed ID: 29394210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
